Bill

Bill > H3194


MA H3194

Resolutions urging the Congress of the United States to update the Drug Addiction Treatment Act of 2000 and remove excessive training requirements mandated for obtaining a waiver to prescribe buprenorphine


summary

Introduced
01/22/2019
In Committee
02/26/2020
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

191st General Court

Bill Summary

By Mr. Ayers of Quincy, a petition of Bruce J. Ayers and others for the adoption of resolutions by the General Court memorializing the Congress of the United States to update the Drug Addiction Treatment Act of 2000 and remove excessive training requirements mandated for obtaining a waiver to prescribe buprenorphine. Veterans and Federal Affairs.

AI Summary

This bill urges the U.S. Congress to update the Drug Addiction Treatment Act of 2000 and remove the excessive training requirements mandated for obtaining a waiver to prescribe buprenorphine, a medication used to treat opioid addiction. The bill highlights the ongoing opioid crisis in the United States, which has led to a public health emergency, and notes that medically-assisted treatment using buprenorphine has proven successful in reducing opioid dependence and addiction. However, the current requirements to prescribe buprenorphine, including an 8-hour training and a separate DEA license, are unreasonably stringent compared to the prescribing of other Schedule III drugs, and are seen as a deterrent for physicians to prescribe this potentially life-saving medication. The bill calls on Congress to take action to address these issues and improve access to treatment for those struggling with opioid addiction.

Committee Categories

Military Affairs and Security

Sponsors (4)

Last Action

Resolutions reported favorably by committee and referred to the committee on House Steering, Policy and Scheduling (on 02/26/2020)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...